INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹73 Cr | ₹62 Cr | ₹50 Cr | ₹40 Cr |
What is the latest Revenue of INDO US BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹50 Cr |
| Mar2021 | ₹40 Cr |
How is Revenue of INDO US BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 42.56 | |
| Mar2024 | ₹73 Cr | 17.96 | |
| Mar2023 | ₹62 Cr | 23.36 | |
| Mar2022 | ₹50 Cr | 24.86 | |
| Mar2021 | ₹40 Cr | - | |
Compare Revenue of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹285.4 Cr | -4% | 12.6% | -36.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹11,825.3 Cr | -4.7% | -1.3% | -6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,968.5 Cr | -6.4% | -17.6% | -18.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,898.1 Cr | -2.7% | -12.1% | -18.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹942.1 Cr | -1.6% | 0.8% | -38.4% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹367.5 Cr | -4.6% | -10.3% | -22.9% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -4% |
12.6% |
-36.3% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses